Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids.

PubWeight™: 1.29‹?› | Rank: Top 10%

🔗 View Article (PMID 7448777)

Published in Cancer Res on January 01, 1981

Authors

M K Buening, R L Chang, M T Huang, J G Fortner, A W Wood, A H Conney

Articles citing this

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest (1997) 3.96

Grapefruit juice-drug interactions. Br J Clin Pharmacol (1998) 2.68

Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci U S A (1989) 2.25

Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets (2008) 1.95

Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc Natl Acad Sci U S A (1989) 1.39

Clinical pharmacology. Possible clinical importance of genetic differences in drug metabolism. Br Med J (Clin Res Ed) (1981) 1.24

Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br J Clin Pharmacol (1993) 1.12

Dietary effects on drug metabolism and transport. Clin Pharmacokinet (2003) 1.11

Involvement of cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer. Environ Health Perspect (1996) 0.99

Polyphenols as inhibitors of carcinogenesis. Environ Health Perspect (1997) 0.92

Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice. Br J Clin Pharmacol (1993) 0.92

The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor. Br J Cancer (1999) 0.90

Antioxidant and anticancer efficacy of hesperidin in benzo(a)pyrene induced lung carcinogenesis in mice. Invest New Drugs (2008) 0.88

Interactions of ingested food, beverage, and tobacco components involving human cytochrome P4501A2, 2A6, 2E1, and 3A4 enzymes. Environ Health Perspect (1994) 0.83

Factors affecting the absolute bioavailability of nifedipine. Br J Clin Pharmacol (1995) 0.83

Paclitaxel metabolism in rat and human liver microsomes is inhibited by phenolic antioxidants. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.80

A Module Analysis Approach to Investigate Molecular Mechanism of TCM Formula: A Trial on Shu-feng-jie-du Formula. Evid Based Complement Alternat Med (2013) 0.80

Alpha-naphthoflavone induces vasorelaxation through the induction of extracellular calcium influx and NO formation in endothelium. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.79

Possible enhancement of the first-pass metabolism of phenacetin by ingestion of grape juice in Chinese subjects. Br J Clin Pharmacol (1999) 0.75

Survey of phytochemical composition and biological effects of three extracts from a wild plant (Cotoneaster nummularia Fisch. et Mey.): a potential source for functional food ingredients and drug formulations. PLoS One (2014) 0.75

Oxidative Stress Triggered by Apigenin Induces Apoptosis in a Comprehensive Panel of Human Cervical Cancer-Derived Cell Lines. Oxid Med Cell Longev (2017) 0.75

Protective Effects of Proanthocyanidin on Cerulein-induced Acute Pancreatic Inflammation in Rats. Gastroenterology Res (2009) 0.75

Articles by these authors

Pharmacological implications of microsomal enzyme induction. Pharmacol Rev (1967) 13.35

Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88

Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res (1982) 4.78

Immune function in mice lacking the perforin gene. Proc Natl Acad Sci U S A (1994) 4.06

Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg (1984) 3.96

Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis (1998) 3.48

Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer (1975) 3.26

Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery (1986) 3.22

Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr (2001) 3.11

Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg (1978) 2.80

Giant hemangiomas of the liver. Ann Surg (1970) 2.70

Orthotopic and heterotopic liver homografts in man. Ann Surg (1970) 2.63

Regional resection of cancer of the pancreas: a new surgical approach. Surgery (1973) 2.43

Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg (1996) 2.39

Epidemiology of cancer of the pancreas. J Natl Cancer Inst (1973) 2.37

Surgical treatment of 297 soft tissue sarcomas of the lower extremity. Ann Surg (1975) 2.31

Major hepatic resection using vascular isolation and hypothermic perfusion. Ann Surg (1974) 2.30

V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev (1996) 2.29

Malignant schwannoma. A clinicopathologic study. Cancer (1973) 2.26

Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum (1988) 2.20

Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res (1988) 2.10

Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results. Ann Surg (1984) 2.03

Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Ann Surg (1977) 1.96

The continuing challenge of retroperitoneal sarcomas. Cancer (1981) 1.95

Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res (1994) 1.91

Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg (1995) 1.91

Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man. Clin Pharmacol Ther (1976) 1.87

The case for and technique of heterotopic liver grafting. Transplant Proc (1979) 1.87

Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons. Proc Natl Acad Sci U S A (1986) 1.83

Permselectivity of the glomerular capillary wall: III. Restricted transport of polyanions. Kidney Int (1975) 1.83

Curcumin is an in vivo inhibitor of angiogenesis. Mol Med (1998) 1.81

Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res (1994) 1.80

Aurintricarboxylic acid: inhibitor of initiation of protein synthesis. Proc Natl Acad Sci U S A (1971) 1.71

Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery (1997) 1.68

The seventies evolution in liver surgery for cancer. Cancer (1981) 1.68

Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res (1991) 1.66

Permselectivity of the glomerular capillary wall to macromolecules. II. Experimental studies in rats using neutral dextran. Biophys J (1975) 1.64

Treatment of primary and secondary liver cancer by hepatic artery ligation and infusion chemotherapy. Ann Surg (1973) 1.53

Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (+)-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene. Proc Natl Acad Sci U S A (1978) 1.53

Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow). Ann Surg (1975) 1.52

Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds, and endogenous substrates. II. Role of the cytochrome P-450 and P-448 fractions in drug and steroid hydroxylations. J Biol Chem (1972) 1.48

Interactions between nutritional factors and drug biotransformations in man. Proc Natl Acad Sci U S A (1976) 1.47

Estrogenic action of DDT and its analogs. Toxicol Appl Pharmacol (1969) 1.46

Effects of oral administration of tea, decaffeinated tea, and caffeine on the formation and growth of tumors in high-risk SKH-1 mice previously treated with ultraviolet B light. Nutr Cancer (1999) 1.46

Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res (1998) 1.45

Clinical manifestations of hepatoma. A review of 6 years' experience at a cancer hospital. Am J Med (1974) 1.42

Endoscopic diagnosis of advanced gastric cancer. Factors influencing yield. Gastroenterology (1975) 1.40

Induction of aryl hydrocarbon hydroxylase in human skin. Drug Metab Dispos (1974) 1.39

Stimulatory effect of brussels sprouts and cabbage on human drug metabolism. Clin Pharmacol Ther (1979) 1.38

Mode of action of tylocrebrine: effects on protein and nucleic acid synthesis. Mol Pharmacol (1972) 1.37

Metabolic interactions among environmental chemicals and drugs. Science (1972) 1.36

Stimulatory effect of oral administration of green tea or caffeine on ultraviolet light-induced increases in epidermal wild-type p53, p21(WAF1/CIP1), and apoptotic sunburn cells in SKH-1 mice. Cancer Res (2000) 1.35

Stimulatory effect of N-phenylbarbital (phetharbital) on cortisol hydroxylation in man. Biochem Pharmacol (1968) 1.35

Enzyme stimulation and inhibition in the metabolism of drugs. Proc R Soc Med (1965) 1.34

The role of radiotherapy in the management of malignant hemangiopericytoma: report of eleven new cases and review of the literature. Cancer (1977) 1.33

Local recurrence of gastric adenocarcinomas after gastrectomy. J Surg Oncol (1981) 1.32

Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (+/-)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice. Cancer Res (1978) 1.31

Adverse effect of pregnancy on melanoma: a reappraisal. Cancer (1976) 1.31

Tendosynovial sarcoma: a clinicopathological study of 136 cases. Cancer (1977) 1.30

Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides. Cancer Res (1976) 1.29

Inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-O-tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice. Cancer Res (1992) 1.27

Experimental use of a gastric flap on an omental pedicle to close defects in the trachea, pharynx, or cervical esophagus. Plast Reconstr Surg (1977) 1.27

Metabolism of benzo[a]pyrene: conversion of (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to highly mutagenic 7,8-diol-9,10-epoxides. Proc Natl Acad Sci U S A (1976) 1.27

Permselectivity of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using dextran sulfate. J Clin Invest (1976) 1.27

Biostatistical basis of elective node dissection for malignant melanoma. Ann Surg (1977) 1.27

Effects of tea, decaffeinated tea, and caffeine on UVB light-induced complete carcinogenesis in SKH-1 mice: demonstration of caffeine as a biologically important constituent of tea. Cancer Res (1997) 1.27

Tumor vascularity as a prognostic factor for hepatic tumors. Ann Surg (1977) 1.26

High mutagenicity and toxicity of a diol epoxide derived from benzo(a)pyrene. Biochem Biophys Res Commun (1976) 1.26

Inhibitors of protein synthesis in eukaryotes: tools in cell research. Fed Proc (1973) 1.26

Adenocarcinoma of the gastric cardia. The choice of gastrectomy. Ann Surg (1980) 1.26

Time course for early adaptive responses to ultraviolet B light in the epidermis of SKH-1 mice. Cancer Res (1999) 1.25

Outcome of treatment for distal bile duct cancer. Br J Surg (1996) 1.25

Harringtonine, an inhibitor of initiation of protein biosynthesis. Mol Pharmacol (1975) 1.25

Mutagenic and cytotoxic activity of benzol[a]pyrene 4,5-, 7,8-, and 9,10-oxides and the six corresponding phenols. Proc Natl Acad Sci U S A (1975) 1.25

Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol Cell Biol (1995) 1.25

Surgical management of carcinoma of the junction of the main hepatic ducts. Ann Surg (1976) 1.25

A sensitive method for the determination and isolation of pentobarbital-C14 metabolites and its application to in vitro studies of drug metabolism. J Pharmacol Exp Ther (1967) 1.24

Primary lymphoma of the liver. Cancer (1988) 1.24

Genetic regulation of coumarin hydroxylase activity in mice. Evidence for single locus control on chromosome. J Biol Chem (1979) 1.24

A case control study of cancer of the pancreas. Cancer (1973) 1.23

Purine overproduction in man associated with increased phosphoribosylpyrophosphate synthetase activity. Science (1973) 1.23

Morphological studies of rejection in canine jejunal allographs. Gastroenterology (1971) 1.23

Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. II. Treatment by intrahepatic chemotherapy. Ann Surg (1984) 1.23

Steady-state visual evoked potentials and travelling waves. Clin Neurophysiol (2000) 1.22

Metabolic consequences of (regional) total pancreatectomy. Ann Surg (1991) 1.22

Cigarette smoke: stimulatory effect of metabolism of 3,4--benzpyrene by enzymes in rat lung. Life Sci I (1971) 1.22

Effects of inducers and epoxide hydrase on the metabolism of benzo(a)pyrene by liver microsomes and a reconstituted system: analysis by high pressure liquid chromatography. Proc Natl Acad Sci U S A (1974) 1.21

Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Carcinogenesis (1995) 1.20